‘Making it Meaningful’: Co-designing an intervention to improve medication safety for people from culturally and linguistically diverse backgrounds accessing cancer services.

This study reports on the process of using an adapted Experienced-Based Co-Design (EBCD) conducted with culturally and linguistically diverse (CALD) consumers and cancer service staff to co-design the novel ‘Making it Meaningful’(MiM) instrument at a cancer service in Australia. Multi-source experiential and contextual information was gathered in phase 1 of the co-design and this evidence, coupled with knowledge gathered via a feedback event was used to inform three co-design workshops in phase 2. A series of meetings were conducted prior to and in between the workshops. Theory was progressively integrated into the workshop content. Two Mandarin speaking CALD consumers and three cancer service staff participated as co-design members. Workshops were supported by a multilingual fieldworker, co-facilitated by researchers and a consumer co-facilitator, and conducted using a hybrid model (face-to-face or online participation). In the first workshop members democratically selected to focus on a strategy to enable CALD consumers to make non-emergency urgent contact with the cancer service for medication related communication. The second workshop resulted in consensus to develop an accessible instrument that would identify appropriate contacts and information sources for medication management between appointments. In the third workshop, the prototype MiM instrument was developed and refined. The MiM is a novel instrument designed with CALD consumers to enhance their knowledge of medication management and empower them to contact cancer service staff about medication safety concerns. Feasibility testing is the next step with successful implementation requiring senior health leadership support and involvement of co-design members as change agents.
Related content
-
Policy & Measurement | Quality & Clinical Excellence
PX Pulse: Consumer Perspectives on Patient Experience in the U.S. – July 2023
We are pleased to share results from the 13th edition of our PX Pulse survey. Conducted in partnership with Ipsos, PX Pulse captures healthcare consumer perspectives of patient experience in the United States. The latest release of PX Pulse reveals affordability and access to hospitals and treatments continue as important issues to consumers. While the
Learn more -
Policy & Measurement | Quality & Clinical Excellence
PX Pulse: Consumer Perspectives on Patient Experience in the U.S. – November 2023
The latest release of PX Pulse reveals the items of greatest importance to healthcare consumers remain consistent from the previous quarter, but perspectives on the quality of care and overall experience saw the lowest scores in the last two years. This issue also explores the critical issues of trust, provider relationships and providing feedback to
Learn more -
Quality & Clinical Excellence
Navigating Conflict in Physician Communication
By Sofie Morgan, MD MBA FACEP CPXP CPC Conflict is integral to the human experience, even for physicians with a strong commitment to professionalism. From my practices as a patient experience professional and an emergency physician, it is clear that conflict often overlies deeper feelings of being misunderstood or undervalued. Yet, in my professional coaching
Learn more